ICTRP Search Portal

Main

Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.

Register:	CTRI
Last refreshed on:	24 November 2021
Main ID:	CTRI/2018/06/014535
Date of registration:	14-06-2018
Prospective Registration:	No
Primary sponsor:	Tata Memorial Hospital
Public title:	Causes of Primary Liver Cancer study
Scientific title:	A comparison of clinic-pathological profile of non-B non-C hepatocellular cancer (HCC) and Hepatitis B or C related HCC
Date of first enrolment:	21-06-2017
Target sample size:	2400
Recruitment status:	Open to Recruitment
URL:	http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=19320
Study type:	Observational
Study design:	Other Method of generating randomization sequence:Not Applicable Method of allocation concealment:Not Applicable Blinding and masking:Not Applicable
Phase:	N/A

Countries of recruitment
India

Contacts

Name:	Dr Vaneet Jearth
Address:	Dept Of Digestive Diseases and Clinical Nutrition, Tata Memorial Hospital, Parel, Mumbai 400012 Mumbai, MAHARASHTRA India
Telephone:
Email:	dr_vaneet_jearth@yahoo.co.in
Affiliation:	Tata Memorial Hospital

Name:	Dr Prachi Patil
Address:	Dept Of Digestive Diseases and Clinical Nutrition, Tata Memorial Hospital, Parel, Mumbai 400012 Chennai, MAHARASHTRA India
Telephone:
Email:	dr_vaneet_jearth@yahoo.co.in
Affiliation:	Tata Memorial Hospital

Key inclusion & exclusion criteria

Inclusion criteria: 1]HCC diagnosed as per standard diagnostic criteria

2]Willing to sign the informed consent form

Exclusion criteria: Previous surgery or interventional therapy for HCC

Age minimum:
Age maximum:
Gender:

Health Condition(s) or Problem(s) studied

Health Condition 1: null- Hepatocellular cancer

Intervention(s)

Primary Outcome(s)

Etiology and demographic features of non-B non-C HCC as compared to HBV/ HCV related HCCTimepoint: Baseline

Secondary Outcome(s)

2. Comparison of outcomes of non-B non-C HCC as compared to HBV/ HCV related HCC

3. To assess the prevalence of metabolic syndrome in subjects with non-B non-C HCC

Timepoint: Baseline, One year follow up

Secondary ID(s)

NIL

Source(s) of Monetary Support

Tata Memorial Hospital

Secondary Sponsor(s)

Ethics review

Status: Approved
Approval date: 12/06/2017
Contact:

IEC-I

Results

Results available:
Date Posted:
Date Completed:
URL:

Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.